BACKGROUND: Epigenetic factors influence stem cell function and other developmental events but their role in prostate morphogenesis is not completely known. We tested the hypothesis that histone deacetylase (HDAC) activity is required for prostate morphogenesis. RESULTS: We identified the presence of class I nuclear HDACs in the mouse urogenital sinus (UGS) during prostate development and found that Hdac 2 mRNA abundance diminishes as development proceeds which is especially evident in prostatic epithelium. Blockade of HDACs with the inhibitor trichostatin A (TSA) decreased the number of prostatic buds formed in UGS explant cultures but not the number of buds undergoing branching morphogenesis. In the latter, TSA promoted an extensive branching phenotype that was reversed by exogenous NOGGIN protein, which functions as a bone morphogenetic protein (BMP) inhibitor. TSA also increased Bmp2 promoter H3K27ac abundance, Bmp2 and Bmp4 mRNA abundance, and the percentage of epithelial cells marked by BMP-responsive phosphorylated SMAD1/5/8 protein. TSA exposed UGS explants grafted under the kidney capsule of untreated host mice for continued development achieved a smaller size without an obvious difference in glandular histology compared with control treated grafts. CONCLUSIONS: These results are consistent with an active role for HDACs in shaping prostate morphogenesis by regulating Bmp abundance.
BACKGROUND: Epigenetic factors influence stem cell function and other developmental events but their role in prostate morphogenesis is not completely known. We tested the hypothesis that histone deacetylase (HDAC) activity is required for prostate morphogenesis. RESULTS: We identified the presence of class I nuclear HDACs in the mouse urogenital sinus (UGS) during prostate development and found that Hdac 2 mRNA abundance diminishes as development proceeds which is especially evident in prostatic epithelium. Blockade of HDACs with the inhibitor trichostatin A (TSA) decreased the number of prostatic buds formed in UGS explant cultures but not the number of buds undergoing branching morphogenesis. In the latter, TSA promoted an extensive branching phenotype that was reversed by exogenous NOGGIN protein, which functions as a bone morphogenetic protein (BMP) inhibitor. TSA also increased Bmp2 promoter H3K27ac abundance, Bmp2 and Bmp4 mRNA abundance, and the percentage of epithelial cells marked by BMP-responsive phosphorylated SMAD1/5/8 protein. TSA exposed UGS explants grafted under the kidney capsule of untreated host mice for continued development achieved a smaller size without an obvious difference in glandular histology compared with control treated grafts. CONCLUSIONS: These results are consistent with an active role for HDACs in shaping prostate morphogenesis by regulating Bmp abundance.
Authors: Vatsal Mehta; Lisa L Abler; Kimberly P Keil; Christopher T Schmitz; Pinak S Joshi; Chad M Vezina Journal: Dev Dyn Date: 2011-09-20 Impact factor: 3.780
Authors: Dana Rathkopf; Bryan Y Wong; Robert W Ross; Aseem Anand; Erika Tanaka; Margaret M Woo; Jing Hu; Andy Dzik-Jurasz; Wei Yang; Howard I Scher Journal: Cancer Chemother Pharmacol Date: 2010-03-09 Impact factor: 3.333
Authors: Berkley E Gryder; Michelle J Akbashev; Michael K Rood; Eric D Raftery; Warren M Meyers; Paulette Dillard; Shafiq Khan; Adegboyega K Oyelere Journal: ACS Chem Biol Date: 2013-09-20 Impact factor: 5.100
Authors: Kimberly P Keil; Vatsal Mehta; Lisa L Abler; Pinak S Joshi; Christopher T Schmitz; Chad M Vezina Journal: Differentiation Date: 2012-08-13 Impact factor: 3.880
Authors: Dana E Rathkopf; Joel Picus; Arif Hussain; Susan Ellard; Kim Nguyen Chi; Thomas Nydam; Erin Allen-Freda; Kaushal Kishor Mishra; Maria Grazia Porro; Howard I Scher; George Wilding Journal: Cancer Chemother Pharmacol Date: 2013-07-03 Impact factor: 3.333
Authors: Rita A Buresh-Stiemke; Rita L Malinowski; Kimberly P Keil; Chad M Vezina; Arie Oosterhof; Toin H Van Kuppevelt; Paul C Marker Journal: Dev Dyn Date: 2012-11-05 Impact factor: 3.780
Authors: Vatsal Mehta; Christopher T Schmitz; Kimberly P Keil; Pinak S Joshi; Lisa L Abler; Tien-Min Lin; Makoto M Taketo; Xin Sun; Chad M Vezina Journal: Dev Biol Date: 2013-02-08 Impact factor: 3.582
Authors: Kimberly P Keil; Vatsal Mehta; Amanda M Branam; Lisa L Abler; Rita A Buresh-Stiemke; Pinak S Joshi; Christopher T Schmitz; Paul C Marker; Chad M Vezina Journal: Endocrinology Date: 2012-10-18 Impact factor: 4.736
Authors: F M Frame; D Pellacani; A T Collins; M S Simms; V M Mann; G D D Jones; M Meuth; R G Bristow; N J Maitland Journal: Br J Cancer Date: 2013-11-12 Impact factor: 7.640
Authors: Sridurga Mithraprabhu; Anna Kalff; Kate H Gartlan; Ioanna Savvidou; Tiffany Khong; Malarmathy Ramachandran; Rachel E Cooke; Kathryn Bowen; Geoffrey R Hill; John Reynolds; Andrew Spencer Journal: Br J Haematol Date: 2020-09-18 Impact factor: 6.998